T-LGL Lymphoproliferative Disorders
1 clinical trials · Condition
◉ Watch T-LGL Lymphoproliferative Disorders
| Record | Firm | Date |
|---|---|---|
| Alemtuzumab (Campath) to Treat T-Large Granular Lymphocyte Leukemia (NCT00345345) | National Heart, Lung, and Blood Institute (NHLBI) | 2006-10-17 |
Track T-LGL Lymphoproliferative Disorders automatically
Every clearance here is in the API, with alerts when new ones post.